Wealth Awesome
TSX closed
Loading markets…
Interactive Brokers: options trading made simple with the IBKR Options Wizard.
Stocks/TSX/AVCN

Avicanna Inc (AVCN : TSX)

$0.10CAD+0.01 (17.65%)Close of 2026-11-13

Common Stock

Follow AVCN

AVCN

Avicanna Inc

Source:WealthAwesomeWealthAwesome
↑ $0.00 (0.00%)
30 day period
$0.09$0.10$0.12Oct 2Oct 26Nov 13

Performance

1 Day

+17.65%

1 Week

-4.76%

1 Month

+0.00%

YTD

-54.55%

The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.

Key Statistics

Market Cap

$13.44M

52W High

$0.28

52W Low

$0.08

P/E Ratio

-

50 Day MA

$0.11

200 Day MA

$0.14

Beta

0.35

Dividend Yield

-

Performance history

AVCN returns since 2023

Avicanna Inc has traded since Nov 2023 in our data, with 0 up years out of 2 full calendar years. Its deepest fall was −85.1% (Mar 2024 to Nov 2026).

1 year / yr

−63.0%

3 years / yr

−36.7%

5 years / yr

—

10 years / yr

—

Calendar-year returns

  • 2023*−14.6%
  • 2024−12.9%
  • 2025−26.2%
  • 2026*−55.6%

* Partial year (first year of data, or year to date).

$10,000 invested in AVCN

  • 1 year ago$3,704
  • 2023 (start of our data)$2,439
Best year
2024: −12.9%
Worst year
2025: −26.2%
All-time high in our data
$1 on Mar 18, 2024 · now −82.5%

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.

Earnings

AVCN earnings history

Avicanna Inc's reported EPS by quarter.

-0.0284-0.01400.0004 24-0324-0624-0925-0325-0625-0926-0326-06 Reported EPS (≥0) Reported EPS (<0) Wealth Awesome
Quarter endingReportedEPSEstimateSurprise
Jun 30, 2026Aug 13, 2026−$0.01——
Mar 31, 2026May 13, 2026−$0.01——
Sep 30, 2025Nov 13, 2025−$0.01——
Jun 30, 2025Aug 14, 2025−$0.01——
Mar 31, 2025May 14, 2025$0.00——
Sep 30, 2024Nov 14, 2024−$0.01——
Jun 30, 2024Aug 14, 2024−$0.02——
Mar 31, 2024May 13, 2024−$0.03——

EPS as reported vs consensus estimate. TSX earnings calendar →

Awesome Portfolio™

Looking past AVCN? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/13/2026$0.09$0.10$0.09$0.10$0.10110,510
11/12/2026$0.09$0.09$0.09$0.09$0.0939,037
11/11/2026$0.10$0.10$0.08$0.09$0.094,125,201
11/10/2026$0.10$0.10$0.10$0.10$0.10564,250
11/9/2026$0.11$0.11$0.10$0.10$0.1031,511
11/6/2026$0.10$0.10$0.10$0.10$0.10107,800
11/5/2026$0.11$0.11$0.10$0.10$0.10100,500
11/4/2026$0.11$0.12$0.11$0.11$0.1111,510
11/3/2026$0.12$0.12$0.11$0.11$0.1123,249
11/2/2026$0.11$0.11$0.10$0.10$0.1034,575

Analyst Price Targets

Based on analyst covering AVCN · as of Sep 17, 2026

📈

Wall Street analysts forecast AVCN stock price to rise 600.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.70

+600.0% Upside

Current Price

C$0.10

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on AVCN's historical volatility

HistoricalForecast68%95%
C$0.02C$0.08C$0.13C$0.19C$0.24C$0.30TodayJul 7Sep 11Nov 13Dec 26Feb 8Mar 23

30-Day Vol

103.5%

Annualized

90-Day Vol

87.9%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.08

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.09C$0.07 – C$0.13
60 trading daysC$0.09C$0.05 – C$0.15
90 trading daysC$0.08C$0.05 – C$0.16

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Avicanna Inc

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific cannabinoid-based candidates to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, as well as Trunerox, an indication-specific drug treatment for seizure associated with Lennox-Gastaut Syndrome and Dravet Syndrome. The company also offers active pharmaceutical ingredients comprising various cannabidiol, tetrahydrocannabinol, and cannabigerol for use in the development and production of food, cosmetics, medical, and pharmaceutical products under the Aureus Santa Marta brand. In addition, it operates MyMedi.ca, a medical cannabis care platform that offers a diverse portfolio of products and bilingual pharmacist-led patient support programs, specialty services to veterans, as well as provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens; and collaborates with public and private payers for adjudication and reimbursement. The company has a research and collaboration agreement with a multinational European based pharmaceutical company to assess its proprietary SEDDS technology in combination with Collaborator's various drug delivery and pharmaceutical formats. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.

Financials

Revenue (TTM)
$25.31M
EBITDA
$-3.11M
Profit Margin
-14.75%
ROE (TTM)
-30.04%
EPS (Diluted)
-0.03
Book Value
0.02

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

Free newsletter

The Tuesday Stock Pick

Tuesday morning

One Canadian stock and the case for it

  • The name with the biggest gap to analyst targets
  • The chart, insider buying and what is driving it
  • A plain-English bottom line, no hype

Free. One email a week. Unsubscribe any time.

Common Questions About AVCN

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
BYLBaylin Technologies Inc$0.14+40.00%
ANRGAnaergia Inc$2.14+16.94%
STNStantec Inc$122.20+13.79%
HWOHigh Arctic Energy Services Inc.$1.34+13.56%
MREMartinrea International Inc.$10.95+13.35%
GRANanoXplore Inc$1.61+11.03%
GMING Mining Ventures Corp.$46.21+9.89%
KELKelt Exploration Ltd.$11.49+8.81%

Free with a Wealth Awesome account

Keep analysing AVCN, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.